Researchers at Texas A&M University have developed an innovative nasal spray formulation that demonstrates the ability to reverse markers of brain aging in preclinical studies. The treatment, which targets neuroinflammatory pathways, showed sustained cognitive improvements lasting for months following just two doses. By delivering therapeutic compounds directly through olfactory pathways, the nasal spray bypasses the blood-brain barrier, reducing systemic side effects while achieving targeted brain tissue penetration. The study revealed measurable enhancements in memory formation and retention, alongside restoration of cellular energy production in regions critical for learning. These findings suggest that anti-inflammatory interventions may represent a promising therapeutic avenue for addressing age-related cognitive decline. While human clinical trials remain necessary, this research offers encouraging preliminary evidence for a novel approach to managing neurological aging. Read the full article on GMJ Newsroom.
Was this article helpful?
